Skip to main navigation
LinkedIn Twitter
  • Investors
  • Careers
Outlook Therapeutics, Inc. Logo
  • About
    • Overview
    • Senior Leadership
    • Board of Directors
  • Pipeline
    • Overview
    • ONS-5010 / LYTENAVA™ OVERVIEW
    • UNMET NEEDS
  • News
  • Contact

SEC Filings

Home / Investors / SEC Filings / 8-K

SEC Filing Details

Document Details

Form
8-K
Filing Date
Jan 31, 2025
Document Date
Jan 30, 2025
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Outlook Therapeutics, Inc.
Issuer
OUTLOOK THERAPEUTICS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT
  • Investor Overview
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Other Shareholder Information
  • Financial Information
    • SEC Filings
  • Analyst Coverage
  • News & Events
    • Press Releases
    • Events
    • In the News
    • Presentations
  • Corporate Governance
    • Governance Highlights
    • Board Diversity Disclosure
    • Senior Leadership
    • Board of Directors
    • Committee Composition
  • Information Request
  • Print Page Print Page
  • Email Page Email Page
  • RSS Feeds RSS Feeds
  • Email Alerts Email Alerts
  • Contact IR Contact IR
© 2018-2026 Outlook Therapeutics, Inc.
This site is intended for a US audience only.
Privacy Policy | Disclaimer | Terms of use